π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
This is a Phase 2a, randomized, open-label, multicenter study to assess the...
Status
Completed
Location
Multiple Locations
Start Date
2015-07-28
Trial ID
NCT02498652
Treatments Being Tested
This study is to examine the hypothesis that administration of RDEA3170 to ...
Status
Completed
Location
Research Site
Start Date
2014-01-05
Trial ID
NCT02078219
Treatments Being Tested
This is a Phase 2a, randomized, open-label, multicenter study to assess the...
Status
Completed
Location
Multiple Locations
Start Date
2014-10
Trial ID
NCT02246673
Treatments Being Tested
This study will assess the serum uric acid lowering effects and safety of 3...
Status
Completed
Location
Multiple Locations
Start Date
2013-08
Trial ID
NCT01927198
Treatments Being Tested
The purpose of this study is to examine the pharmacokinetic and pharmacodyn...
Status
Completed
Location
Multiple Locations
Start Date
2015-11
Trial ID
NCT02608710
Treatments Being Tested
This study will explore the safety, tolerability, and serum uric acid lower...
Status
Completed
Location
Multiple Locations
Start Date
2013-06
Trial ID
NCT01872832
Treatments Being Tested
The purpose of this study is to determine the relative bioavailability of R...
Status
Completed
Location
Multiple Locations
Start Date
2015-05-01
Trial ID
NCT02448368
Treatments Being Tested
The purpose of this study is to explore the pharmacodynamics (PD), pharmaco...
Status
Completed
Location
Research Site
Start Date
2014-12
Trial ID
NCT02317861
Treatments Being Tested